# Zhejiang Starry Pharmaceutical

> Zhejiang Starry Pharmaceutical is a VC fund in Hangzhou backing Biotechnology and Pharmaceutical. See 2 investments, check sizes, portfolio. Updated Aug 2026.

- Type: VC Fund
- Location: Hangzhou, China
- Total investments: 2
- Last investment: Mar 2026
- Lead investor: 50%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/company/zhejiang-starry-pharmaceutical-co.-ltd/about/
- Website: http://www.starrypharm.com

Zhejiang Starry Pharmaceutical is a VC fund in Hangzhou focused on Biotechnology and Pharmaceutical. Zhejiang Starry Pharmaceutical Co., Ltd.(hereinafter referred to as Starry Pharma), established in 1997, is a national high-tech enterprise specialized in R&D, manufacture and marketing of active ingredient and intermediate X-CT non-ionic contrast agent series and Fluoroquinolones series.

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Biotechnology | 2 | 100% |
| Pharmaceutical | 2 | 100% |
| Manufacturing | 1 | 50% |
| Medical Device | 1 | 50% |

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Series A | 1 | 50% |
| Corporate Round | 1 | 50% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Ruishi Pharmaceutical | Ruishi Pharmaceutical is an innovative company specializing in pharmaceutical CDMO (Contract Development and Manufacturing Organization) services, providing end-to-end solutions that include drug research and development, process optimization, clinical trial material production, and large-scale commercial manufacturing, while maintaining highstandards of quality, regulatory compliance, and technological expertise to support global pharmaceutical partners. |  | Corporate Round | Mar 23, 2026 |  |
| Yannuo Pharmaceutical | Yannuo Pharmaceutical is a high-tech enterprise focusing on the research and development of complex injections. It has three main drug research and development technology platforms: liposomes, nanoparticles, and microspheres. Relying on the advanced drug delivery technology platform, the company adheres to the clinical needs-oriented and conductsresearch and development of small molecule drugs, nucleic acid drugs, peptides, and protein drugs. Deepen development and industrialization, focusing on the tumor, contrast agents, anesthesia and pain, and other therapeutic areas. |  | Series A | Jul 07, 2023 |  |

2 of 2 investments shown.

## Co-investors
- [Zhejiang Huahai Pharmaceutical](https://shizune.co/investors/profile/zhejiang-huahai-pharmaceutical) — VC Fund, 1 deal together

## Similar investors

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund

## FAQ

### What does Zhejiang Starry Pharmaceutical invest in?

Zhejiang Starry Pharmaceutical invests primarily in Biotechnology, Pharmaceutical and Manufacturing startups, most often at Series A and Corporate Round stage. Most of the 2 investments tracked by Shizune back companies in China. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did Zhejiang Starry Pharmaceutical last invest?

The most recent investment recorded for Zhejiang Starry Pharmaceutical closed in Mar 2026. Shizune tracks 2 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co